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Abstract
Background: Congenital muscular torticollis (CMT) is characterized by thickening and/or tightness of the unilateral
sternocleidomastoid muscle (SCM), ending up with torticollis. Our aim was to identify differentially expressed genes
(DEGs) and novel protein interaction network modules of CMT, and to discover the relationship between gene
expressions and clinical severity of CMT.
Results: Twenty-eight sternocleidomastoid muscles (SCMs) from 23 subjects with CMT and 5 SCMs without CMT
were allocated for microarray, MRI, or imunohistochemical studies. We first identified 269 genes as the DEGs in
CMT. Gene ontology enrichment analysis revealed that the main function of the DEGs is for extracellular region
part during developmental processes. Five CMT-related protein network modules were identified, which showed
that the important pathway is fibrosis related with collagen and elastin fibrillogenesis with an evidence of DNA
repair mechanism. Interestingly, the expression levels of the 8 DEGs called CMT signature genes whose mRNA
expression was double-confirmed by quantitative real time PCR showed good correlation with the severity of CMT
which was measured with the pre-operational MRI images (R2 ranging from 0.82 to 0.21). Moreover, the protein
expressions of ELN, ASPN and CHD3 which were identified from the CMT-related protein network modules
demonstrated the differential expression between the CMT and normal SCM.
Conclusions: We here provided an integrative analysis of CMT from gene expression to clinical significance, which
showed good correlation with clinical severity of CMT. Furthermore, the CMT-related protein network modules
were identified, which provided more in-depth understanding of pathophysiology of CMT.
Background
Congenital muscular torticollis (CMT) is one of the most
common musculoskeletal problems in children. The inci-
dence of CMT has been reported to be as high as 3.92% in
neonates [1,2]. From the clinical point of view, CMT is
characterized by a thickening and/or tightness of the uni-
lateral sternocleidomastoid muscle (SCM), and the end
result is limited neck motion [2,3]. Currently we believe
that CMT may be caused by different mechanisms at dif-
ferent stages of either the prenatal or perinatal period.
CMT is known not to occur in the postnatal period, indi-
cating that some characteristics of the fetal developing
muscles are critical for the development of CMT.
However, our understanding of the CMT characteristics is
limited. Moreover, the pathogenesis and pathophysiology
of CMT still remains elusive while fetal mal-positioning in
the uterus, birth trauma and ischemia of the SCM during
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either the prenatal or perinatal period have been widely
proposed as the causes of CMT [4-6].
Currently, the main histopathologic finding of CMT is
known to be interstitial fibrosis [7,8]. Fibrosis leads to a
reduction of the mobile proton density, and so this would
show hypointensity on both the T1- and T2-weighted
magnetic resonance images (MRI). If the fibrosis is more
localized, then localized low signal intensity is observed. If
the fibrosis is diffuse, then the entire SCM muscle shows
diffuse hypointensity. About 90% of the cases of CMT are
known to be cured with only stretching exercises without
causing any musculoskeletal complications since they have
small amount of fibrosis [9]. However, about 10% of the
cases of CMT have a large amount of dense connective
tissue within the SCM, and this shows more hypointensity
on both the T1- and T2-weighted MRIs. This is the most
severely involved subgroup of CMT and these cases hardly
respond to stretching exercises. Therefore, surgical release
is needed for this subgroup of CMT in order to minimize
the secondary musculoskeletal complications of CMT.
Meanwhile, microarray has emerged as a fundamental
tool for studying gene expressions and genome-wide
microarray expression analysis is a useful tool for getting a
comprehensive picture of the gene expression at the mole-
cular level, even without having prior knowledge of the
major genes or susceptibility loci for a certain disease [10].
To the best of our knowledge, however, there has been no
previous study that has investigated the gene expression
signature of CMT.
Here we tried to discover the novel pathways related
with the pathophysiology of CMT through identifying a
gene and protein expression signature of the subjects with
CMT who needed surgical release. The objectives of this
study were 1) to identify a gene expression signature that
was differentially expressed in the tissue with CMT com-
pared to the tissue without CMT, 2) to discover the novel
protein interaction network modules related with the
pathophysiology of CMT, 3) to identify correlation
between the gene expression profiling and the clinical
severity of CMT, 4) to demonstrate expression of the pro-
teins encoded by the differentially expressed genes (DEGs)
in CMT tissue; and 5) to provide an integrative analysis of
gene expression profiling with clinical severity of CMT
and the expression of proteins encoded by DEG.
Methods
Acquisition of the tissue with CMT (T-CMT) and the
tissue without CMT (T-control)
This study was approved by the Institutional Research
Board of Ajou University Medical Center, Suwon, South
Korea. Twenty-eight subjects (23 subjects with CMT and
5 subjects without CMT) were finally enrolled in this
study. For the microarray or quantitative real-time PCR
(QRT-PCR) and MRI analyses, 26 subjects with CMT
originally participated in this study. Myectomy was done
at the lower end of the SCM about 1 centimeter above the
clavicle. All the 26 subjects who agreed to participate in
this study understood that the removed muscle blocks
from the surgery would be used for the analyses. Each
muscle block from 26 subjects was divided into the
T-CMT and the T-control by the third author’s visual
assessment of their gross appearance. While the reddish
part with a normal muscle appearance was considered as
T-control, the whitish cord-like part was considered
as T-CMT. Since the muscle blocks of 4 subjects had only
T-CMT, those subjects were not enrolled. Another 4 sub-
jects showed poor quality of their RNA and they were also
excluded. Therefore, 18 subjects were finally enrolled in
these analyses. For the imunohistochemical (IHC) analysis,
additional 5 subjects with CMT were enrolled. Muscle
block were obtained as the same procedure described
above. Independent normal SCM muscles for the IHC
were obtained from the Ajou Human Bio-Resource Bank,
which provided the normal SCM muscle of 5 subjects who
underwent radical neck dissection for the head and neck
tumor.
RNA isolation from both the T-CMT and the T-control
The muscle tissue was stored in RNAlater RNA Stabili-
zation Reagent (Applied Biosystems/Ambion, Austin,
TX, USA) immediately after surgery to preserve the
RNA. The total RNA was isolated from the tissue using
TRIzol reagent (Invitrogen, Carlsbad, CA, USA) accord-
ing to the manufacturer’s instructions.
Genome-wide mRNA expression profiling using
microarray
Seven paired microarray experiments (a total of 14)
were done using an Affymetrix GeneChip Human Gene
1.0 ST Array (Affymetrix, Santa Clara, CA, USA) which
offers whole-transcript expression profile. 300ng of total
RNA extracted from each sample was used as input into
the Affymetrix procedure as recommended by the man-
ufacture’s protocol (http://www.affymetrix.com). Robust
Multiarray Averaging (RMA) method was used for
microarray normalization and summarization. When
multiple probes per gene were available, we averaged
the values of corresponding probes. We applied a quan-
tile normalization method across samples.
Identification of the DEGs of CMT
The fold change of the expression level was calculated
as follows:
Fold change = T − CMT∗/T − control† if T − CMT∗ > T − control†
Fold change = − (T − control†/T − CMT∗) if T − CMT∗ ≤ T − control†,
where T-CMT* means the expression level of a gene
of the T-CMT, and T-control† means the expression
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level of the same gene of the T-control. DEGs were
identified when genes met the following two conditions
at once: 1) genes showing a significant difference of
expression between the T-CMT and the T-control (p <
0.05; using a Student t test), and 2) genes showing more
than |2| fold change between the T-CMT and the
T-control in more than half subjects (here, >3).
Examination of the discriminant power of the DEGs
between the T-CMT and the T-control
Principal component analysis (PCA) was done using
MATLAB R2007a (MathWorks Inc., Natick, MA, USA).
The clustering methods such as a k-means clustering
method and a hierarchical clustering method were done
using the TM4 software [10].
Gene ontology enrichment analysis
We used functional annotation tools called DAVID (the
Database for Annotation, Visualization and Integrated
Discovery) [11], and GOEAST (the Gene Ontology
Enrichment Analysis Software Toolkit) [12] to find
enriched gene ontology terms in identified DEGs.
Identification of the CMT-related protein network
modules
We set up the protein-protein interactions (PPIs) and
protein-DNA interactions (PDIs) for Homo sapiens. For
the PPIs, we used the data of Lee et al. [13] and the
results of several recent genome-wide studies [14-17].
The PPIs consist of 80,970 interactions among 10,819
human proteins. For the PDIs, we extracted 1,539 inter-
actions using the TRANSFAC database [18]. To discover
the CMT-related PPIs or PDIs, the prepared PPIs, PDIs
and the list of the identified DEGs from this research
were imported into Cytoscape (http://www.Cytoscape.
org) with their fold change [19]. MCODE was used to
find the CMT-related protein network modules [20].
Network score was calculated based on complexity and
density of each sub-graph. A module with more than 1
MCODE score was considered significant. Post filtering
was performed to remove low-quality modules. In the fil-
tering process, the part of each module shown consistent
expression and high connectivity were selected as a final
module through manual review. Finally, modules which
include at least one protein encoded by DEG and other
proteins their association with CMT was previously
known were selected as CMT-related protein network
modules. For selected five CMT-related modules, net-
work ontology analysis (NOA) published by Wang et al.
which perform gene ontology analysis on network mod-
ule was conducted to define function of the five CMT-
related modules [21]. A GO term of which p-value was
less than 0.1 was considered significant.
Quantitative real-time PCR of DEGs
Genome-wide mRNA expression profiling using microar-
ray was validated by QRT-PCR. We selected 8 among 269
DEGs for the validation. 7 were DEGs which show top dif-
ference expression in fold change and the t-test (p value)
in the microarray study. The other one is S100A4, which
was a component of one of CMT-related protein network
modules and showed key role as the first split point in
decision tree model discriminating T-CMT and T-control
(Figure S1 in Additional file 1). Eight DEGs were as fol-
lows: thrombospondin 4 (THBS4), fibromodulin (FMOD),
collagen, type XIV, alpha 1 (COL14A1), cathepsin K
(CTSK), epidermal growth factor (EGF)-like repeats and
discoidin I-like domains 3 (EDIL3), lysyl oxidase (LOX),
secreted frizzled-related protein 4 (SFRP4), and S100 cal-
cium binding protein A4 (S100A4). QRT-PCR was done
for 11 paired (T-CMT and T-control) muscle tissues (a
total of 22 specimens) from 11 independent subjects. Gly-
ceraldehyde-3-phosphate dehydrogenase (GAPDH) was
used as an internal control. R2 of the linear regression ana-
lysis was used for evaluating the degree of correlation
between the microarray and the QRT-PCR expression
levels. See the Table S1 in Additional file 1 for the primers
used here.
Correlation between the expression levels of QRT-PCR
and the color intensity of lesions on MRI
Eleven subjects with CMT were recruited in both
QRT-PCR study and the pre-operational MRI study.
The fold changes from the QRT-PCR described above
were used as the gene expression level. The difference
of grey color intensity between the SCM with CMT
(SCM-CMT) and the contralateral SCM (SCM-control)
on the pre-operational neck MRI was used as an indi-
cator of the radiological severity. In terms of pathology,
CMT is interstitial fibrosis with/without aberrant ten-
don-like dense connective tissue. Fibrosis will lead to a
reduction of the mobile proton (hydrogen ion) density,
and so this will show as a darker grey color with a
lower scale on both the T1- and T2-weighted MR
images. Thus, darker grey color with a lower scale
means much fibrosis within the SCM-CMT. We mea-
sured the mean intensity of the SCM-CMT on the
axial T1 weighted, pre-operational MRI image that
showed lowest signal intensity using the region of
interest (ROI) method. The mean intensity of the
SCM-control was measured on the same axial T1
weighted image using the same ROI. The mean inten-
sity of each SCM was divided by that of its correspond-
ing SCM-control for normalization. Therefore, the
difference between the SCM-CMT and the SCM-con-
trol was calculated as follows for the independent 11
subjects used in the QRT-PCR analysis:
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Difference of grey color intensity = (the mean intensity
of the SCM-control - the mean intensity of the SCM-
CMT)/the mean intensity of the SCM-control.
Next, we compared the QRT-PCR expression level of
the identified 8 DEGs with the difference of grey color
intensity of the 11 subjects. R2 of the linear regression ana-
lysis was used for evaluating their degree of correlation.
Immunohistochemical examination
For immunohistochemistry, 4-µm thick sections of forma-
lin-fixed, paraffin-embedded tissue blocks were cut
from the SCM muscles with CMT and the normal SCM.
Sections were deparaffinized in xylene, rehydrated in
graded alcohols, followed by antigen retrieval. The endo-
genous peroxidase activity was blocked by Hydrogen Per-
oxide Block (Thermo Fisher Scientific, Fremont, CA).
Sections were then placed in an automated IHC stainer
(Lab Vision Autostainer LV-1; Thermo Fisher Scientific,
Fremont, CA) for immunohistochemistry and incubated at
4℃ with primary antibodies against elastin, asporin,
CHD3, tenascin, THBS4, EDIL3 (Table S2 in Additional
file 1). EDIL3 and ASPN were selected because two were
top 2 over-expressed DEGs. The remaining 4 proteins
were selected from the CMT-related network modules
(ELN, CHD3, TNC, and THBS4). The primary antibodies
were detected using the UltraVision LP Detection System
(Thermo Fisher Scientific, Fremont, CA). The reaction
products were developed with the Vector NovaRED® sub-
strate kit for peroxidase (Vector Laboratories, Burlingame,
CA) for 5 minutes, and hematoxylin counterstaining was
then applied. The IHC staining was assessed in the CMT
and normal SCM. The intensity of IHC staining was
scored semi-qauntitatively as follows (0-3): 0, no immune-
expression; 1, weak immune-expression; 2, moderate
immune-expression; 3, marked immune-expression. The
Mann-Whitney test was used to test significance of the
intensity of IHC staining between the CMT and normal
SCM. P values less than 0.05 were considered statistically.
Results
The characteristics of the subjects
Twenty-eight subjects were finally enrolled in the RNA
microarray study (n = 7), MRI and QRT-PCR study (n =
11) or IHC studies (n = 5 for CMT and n = 5 for normal
SCM) (Figure 1). The demographic characteristics of the
23 subjects with CMT are presented in Table S3 in Addi-
tional file 1. Except for one subject who was 39 years old,
the age of the remaining 22 subjects at the time of opera-
tion for CMT ranged from 5 months old to 12 years old
with the mean age being 50.82 ± 97.63 months old. All the
subjects were born at full term with normal birth weight.
The method of child birth was vaginal delivery for 18 sub-
jects and Cesarean section for 5 subjects. Three subjects
(subject#5 in the microarray study, subjects #1 and #4 in
the QRT-PCR study) did not receive any physical therapy
for CMT, which might lower the concern on any possible
influence of the physical therapy on the gene expression of
the CMT. The subject #5 in the microarray study suffered
from CMT since his birth without having any physical
therapy for CMT. He underwent the surgery at the age of
39 years old.
The differentially expressed genes of CMT
Overall, 33,297 probes covering 20,435 genes was signifi-
cantly expressed from microarray gene expression analysis.
Among the 20,435 genes, 269 genes (1.32%) were identi-
fied as DEGs. 165 genes (61.34%) were over expressed and
104 genes (38.66%) were down expressed in the T-CMT,
compared to those in the T-control. The top-20 over-
expressed genes based on their fold changes are listed in
Table 1. EGF-like repeats and discoidin I-like 3 (EDIL3;
fold change = 9.852), asporin (ASPN; 8.240), thrombospon-
din 4 (THBS4; 8.197), tenomodulin (TNMD; 7.576) and
nephroblastoma (NOV; 5.583) were the 5 most over
expressed genes in the T-CMT (Table 1). Among the 104
down-expressed genes, aquaporin 4 (AQP4) was mostly
significant (fold change = -9.814; Table S4 in Additional
file 1).
Clustering and principal component analyses of
expression levels of DEGs distinguished CMT from
non-CMT tissue
The 269 DEGs showed a clear separation between the
T-CMT and the T-control in the two dominant PCA
components (Figure 2A). The heat map of the hierarchi-
cal clustering method also showed that the gene expres-
sion levels of all the DEGs were quite different between
the T-CMT and the T-control (Figure 2B). Finally, we
clustered DEGs with a k-means clustering algorithm
according to their expressions (Figure 2C), showing that
the DEGs can be divided into two groups according to
their expression pattern. Taken together, these PCA and
clustering results imply that the expression patterns of
DEGs are distinct and discriminative according to the
T-CMT or the T-control.
Gene ontology enrichment analysis of DEGs revealed
dysregulated functions in CMT
Next, the gene ontology (GO) enrichment analysis was
conducted to define the dysregulated functional cate-
gories of the DEGs in terms of the biological processes,
the cellular components and the molecular functions.
The results of GO enrichment analysis of the 269 DEGs
of CMT are illustrated in the pie diagrams (Figure 2D-
F). In terms of biological processes (Figure 2D), the
most significant functional term was ‘developmental
process’, where 80 genes among the selected 269 DEGs
were related to the term (p-value = 1.98E-8). Moreover,
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‘biological adhesion’ (p-value = 4.89E-8, 31 genes) and
‘multicellular organismal process’ (p-value = 3.83E-4, 84
genes) were also significantly enriched. In terms of the
cellular components (Figure 2E), ‘extracellular region
part’ (p-value = 9.43E-22, 58 genes) and ‘extracellular
region’ (p-value = 2.65E-19, 80 genes) were most
enriched in the DEGs of CMT. In relation to the mole-
cular function (Figure 2F), the significant functional
categories of the DEGs were ‘binding’ (p-value = 3.30E-
6, 193 genes) and ‘structure molecule activity’ (p-value =
3.83E-4, 84 genes). The meaningful subordinate con-
cepts of the functional categories are shown in Figure
S2 in Additional file 1. In summary, the terms related to
developmental process, extracellular region, and binding
were significantly dysregulated functions in the DEGs of
CMT.
Protein network analysis of differentially expressed
genes indicated CMT-related functional modules
The number of modules with more than 1 MCODE
score was 8. Among them, 5 modules included at least
one protein encoded by DEG and another protein their
association with CMT was previously known. These 5
modules were selected as CMT-related protein network
modules and they have densely known protein interac-
tions among the identified DEGs (Figure 3). The module
1 shown in Figure 3A was related to the over-expression
of the Mi-2/nucleosome remodeling and the histone
deacetylation (NuRD) complex which is known to a reg-
ulator of DNA damage responses [22]. The clinical
implication of this module is that there might be biolo-
gical responses to DNA damage within the CMT tissue.
In the network module 2 (Figure 3B), the proteins
Figure 1 The overview of the method. Twenty eight subjects were allocated in the microarray study, the MRI and quantitative real-time PCR
(QRT-PCR) study, and immunohistochemical study, respectively. In the microarray study, differentially expressed genes (DEGs) of T-CMT were
identified (A-B). The discriminant power of the DEGs (C) was examined and the gene ontology enrichment analysis (D) was done. The CMT-
related network modules (E) were identified. In the MRI and QRT-PCR study, the pre-operational neck MRI was taken and analyzed (F-G). The
expression level of 8 selected DEGs in T-CMT was measured through the QRT-PCR assay (H). The correlation between the expression level of the
DEGs and pre-operational MRI findings was examined (I). The expression of the proteins encoded by the DEGs of CMT was examined using
immunohistochemical examination for 5 subjects with CMT compared to the normal SCM muscles from the Bio-resource Bank (J-K).
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related to elastic fiber formation such as elastin (ELN),
fibrilin 1 (FBN1) and fibrilin 2 (FBN2) were up-regu-
lated in CMT. Elastic fiber is composed of FBN and
ELN where the FBNs appear to provide a scaffold for
the deposition of ELN. Moreover, module 3 (Figure 3C)
represents over-expression of collagen fibrillogenesis
including tenacin (TNC) which is an extracellular pro-
tein functioning as an organizer of collagen fibrillogen-
esis. Alpha-parvin is a protein that is encoded by parvin
alpha (PARVA) in humans. Members of the parvin
family, including PARVA, are actin-binding proteins.
The network module 4 (Figure 3D) was related to the
collagen fibrillogenesis, where thrombospondins (THBS)
which is known to play a regulator in collagen fibrillo-
genesis was one of mostly over expressed genes. Lastly,
the network module 5 (Figure 3E) was related to micro-
tubular dimerization, representing cytoskeletal rearran-
gement related with mechanical strain, especially
regarding microtubule dynamic instability. S100A4 and
Rho GTPase activating protein 1 (ARHGAP1) help
microtubule to depolymerize if there is cellular strain,
while septin 2, 6, 7 work together to maintain microtub-
ular polymerization.
In network ontology analysis, we can confirm our
findings in protein network analysis that module 4 was
related to the collagen fibrillogenesis and module 5 to
cytoskeletal part (Table 2). There was no GO term of
which p-value was less than 0.1 in module 1.
QRT-PCR confirmed the differential expression of the
CMT-gene signature
These expression levels of the 8 genes from the QRT-
PCR were well correlated with those from microarray
analysis even though the samples are independent
between them (0.41 of R2, Figure 4 and S3 in Additional
file 1). We called the eight confirmed genes as “CMT sig-
nature genes (CSGs)” in the further analysis.
The gene signature of CMT highly correlated with
radiological severity of CMT
We examined relationship between the gene expression
levels of CSGs and the radiological severity of CMT. The
MRIs of 11 subjects were shown in Figure 5A and S4 in
Additional file 1, where red and green circles indicate the
cross sectional areas of the SCM with and without CMT,
respectively. The red arrows indicate the lowest signal area
of CMT. We observed that the expression changes of
CSGs from QRT-PCR were well correlated with the inten-
sity difference between the SCM-CMT and the SCM-
control on MRI images (R2 = 0.82~0.21; Figure 5B). In the
uppermost left graph of Figure 5B, for example, THBS4
showed a high correlation between the fold change of the
expression level and difference in color intensity of the tis-
sues with/without CMT (R2 = 0.82). The subject #3 with
the highest degree of THBS4 over-expression in the tissue
with CMT showed the biggest difference in the grey inten-
sities of MRI images of SCM with/without torticollis.
Table 1 The top-20 over-expressed genes (sorted according to the fold changes).
Gene symbol Full name of the gene Gene ID Fold change of the expression level p-value
EDIL3 EGF-like repeats and discoidin I-like domains 3 10085 9.852 0.01
ASPN asporin 54829 8.240 0.002
THBS4 thrombospondin 4 7060 8.197 0.004
TNMD tenomodulin 64102 7.576 0.047
NOV nephroblastoma overexpressed gene 4856 5.583 0.002
SFRP2 secreted frizzled-related protein 2 395546 4.564 0.021
SFRP4 secreted frizzled-related protein 4 6424 4.534 <0.001
MXRA5 matrix-remodelling associated 5 25878 4.506 0.019
FMOD fibromodulin 2331 4.252 0.014
CTSK cathepsin K 1513 4.099 0.001
COL14A1 collagen, type XIV, alpha 1 7373 4.022 0.001
LOX lysyl oxidase 153455 4.010 <0.001
FAM38B family with sequence similarity 38, member B 63895 4.000 0.016
BGN biglycan 633 3.764 <0.001
GXYLT2 glucoside xylosyltransferase 2 727936 3.604 0.01
FIBIN fin bud initiation factor homolog 387758 3.547 <0.001
STEAP2 six transmembrane epithelial antigen of the prostate 2 261729 3.471 0.001
LUM lumican 4060 3.440 <0.001
DPT dermatopontin 1805 3.401 0.003
THY1 Thy-1 cell surface antigen 7070 3.390 0.002
Bolds are the DEGs which were double confirmed by QRT-PCR study.
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On the other hand, the subject #1, who has smallest differ-
ence in the THBS4 expression level, showed the lowest
degree of difference in grey color intensity in its MRI
images. This also indicates that the subjects who showed
lower signal intensity on the pre-operational T1-weighted
MRI tended to show higher expression levels of THBS4 as
Figure 2 Discriminant powers of the DEGs between T-CMT and T-control and gene ontology enrichment analysis. The result of principal
component analysis (PCA) showing a visible separation of the expression level of 269 DEGs between the T-CMT and the T-control (A). The
hierarchical congregating method of the heat map shows the distinct differences of expression levels of the 269 DEGs between the T-CMT and
the T-control (B). The result of k-means clustering method showing that DEGs can be divided into two groups according to their expression
pattern (C). The pie diagram showing the GO enrichment analysis in terms of the biological processes, the cellular components, and molecular
functions of the 269 DEGs of CMT. “n” indicates the number of genes having a corresponding GO term and “p” indicates its p-value (D-F).
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Figure 3 Five CMT-related network modules. The solid lines indicate the interactions between protein and protein. The oval shaped nodes
mean proteins and the diamond shaped nodes represent proteins or DNAs depending on their role in interactions. The nodes with a
highlighted border are DEGs or the proteins encoded by DEGs. The node color means the degree of the expression level of a gene in T-CMT as
compared to that of T-control, where red means over-expression and blue means down-expression in the T-CMT. (A) The process of finding
CMT-related network modules. The most over expressed protein in this module was the chromodomain helicase DNA-binding protein 3 (CHD3).
CHD3 is one of the core subunits of Mi-2/NuRD complexes which is a novel regulator of DNA damage responses. (B) A modules showing
proteins such as elastin (ELN), fibrilin 1 (FBN1) and fibrilin 2 (FBN2), which are related with elastic fiber formation. (C) A module showing over-
expression of collagen fibrillogenesis, including tenacin (TNC), alpha-parvin (PARVA) and Type VI collagen A3. TNC is an extracellular protein that
functions as an organizer of collagen fibrillogenesis. (D) A module showing that thrombospodins (THBS), which are regulators of collagen
fibrillongenesis, are over-expressed. (E) A module showing microtubular dimerization, representing cytoskeletal rearrangement. S100A4 and Rho
GTPase activating protein 1 (ARHGAP1) help microtubule to depolymerize if there is cellular strain, while septin 2, 6 and 7 work together to
maintain microtubular polymerization.
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compared to that of the T-control. Similar correlations
can be observed for the seven other genes, including
FMOD (R2 = 0.5763), COL14A1 (R2 = 0.4295), CTSK
(R2 = 0.4457), EDIL3 (R2 = 0.3072), LOX (R2 = 0.4046),
SFRP4 (R2 = 0.233), and S100A4 (R2 = 0.2105). Therefore,
the expression level changes of the CSGs were well corre-
lated with the difference in grey color intensity of SCM
with/without CMT indicating the clinical severity of CMT.
Expression of the proteins encoded by the differentially
expressed genes of CMT
Expression of 6 proteins encoded by the DEGs of CMT was
examined by a semi-quantitation of IHC assay (Figure 5C,
Table S5 in Additional file 1). IHC examination showed sig-
nificantly increased immune-expression of ELN, ASPN, and
CHD3 encoded by the 3 DEGs including ELN, ASPN, and
CHD3 compared to the normal SCM (p< 0.05). However,
the proteins such as TNC, THBS4 and EDIL3 did not show
high increased expression in the CMT tissue.
Discussion
This research provides an integrative analysis of gene
expression profiling with clinical severity of CMT and the
expression of proteins encoded by DEG. Furthermore, the
CMT-related network modules were identified, which pro-
vided more in-depth understanding of pathophysiology of
CMT. The differentially expressed genes of CMT were
first identified from microarray analysis, where the main
deregulated function of the DEGs was related to the extra-
cellular region part during the developmental processes.
The gene expression signatures of CMT was first charac-
terized by the over-expression of collagen and elastin
fibrillogenesis along with the evidence of DNA repair
mechanism and the cytoskeletal rearrangement possibly
Table 2 Gene ontology terms of CMT-related functional modules revealed by network ontology analysis.
Module GO
domain
GO term Related interaction p-value
Module
2
BP developmental process DCN-ELN, ELN-FBN1, ELN-FBN2, DCN-FBN1, FBN1-FBN2 0.0839
Module
3
BP cell division SEPT2-SEPT7, SEPT2-SEPT6, SEPT6-SEPT7 0.0503
BP cell cycle SEPT2-SEPT7, SEPT2-SEPT6, SEPT6-SEPT7 0.0503
CC septin complex SEPT2-SEPT7, SEPT2-SEPT6, SEPT6-SEPT7 0.0503
CC cell cortex part SEPT2-SEPT7, SEPT2-SEPT6, SEPT6-SEPT7 0.0503
Module
4
BP signaling ITGB1-ITGB5, ITGA5-ITGB1, ITGB1-TNC, ITGA8-ITGB1, ITGA5-ITGB5, ITGA5-TNC, ITGA8-TNC 0.0091
BP response to stimulus ITGB1-PXN, ITGA5-ITGB1, ITGB1-TNC, ITGA8-ITGB1, ITGA5-TNC, ITGA8-TNC 0.0521
BP biological adhesion PARVA-PXN, ITGB1-PXN, ITGB5-PXN, ITGB1-ITGB5, COL6A3-ITGB1, ITGA5-ITGB1,
ITGB1-TNC, ITGA8-ITGB1, ITGA5-ITGB5, COL6A3-ITGA5, ITGA5-TNC, ITGA8-TNC
0.0768
BP cell adhesion PARVA-PXN, ITGB1-PXN, ITGB5-PXN, ITGB1-ITGB5, COL6A3-ITGB1, ITGA5-ITGB1,
ITGB1-TNC, ITGA8-ITGB1, ITGA5-ITGB5, COL6A3-ITGA5, ITGA5-TNC, ITGA8-TNC
0.0768
BP signaling pathway ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0845
BP cell-substrate adhesion ITGB1-PXN, ITGB5-PXN, ITGB1-ITGB5, ITGA8-ITGB1 0.0845
BP cell-matrix adhesion ITGB1-PXN, ITGB5-PXN, ITGB1-ITGB5, ITGA8-ITGB1 0.0845
BP cell surface receptor linked
signaling pathway
ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0845
BP integrin-mediated signaling
pathway
ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0845
CC integral to membrane ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0621
CC intrinsic to membrane ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0621
CC receptor complex ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0621
CC integrin complex ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0621
MF signal transducer activity ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0621
MF receptor activity ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0621
MF molecular transducer
activity
ITGB1-ITGB5, ITGA5-ITGB1, ITGA8-ITGB1, ITGA5-ITGB5 0.0621
Module
5
CC postsynaptic density DLG2-ERBB4, DLG2-DLG4, DLG4-ERBB4 0.0116
CC cytoskeletal part DLG2-ERBB4, DLG2-DLG4, DLG4-ERBB4 0.0116
CC synapse part DLG2-ERBB4, DLG2-DLG4, DLG4-ERBB4 0.0116
Only GO terms of which p-values were less than 0.1 were listed. GO, Gene Ontology; BP, biological process; MF, molecular function; CC, cellular component
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related with mechanical damage. Furthermore, the pre-
operational MRI images of CMT were shown to be corre-
lated well with the gene expression signature of CMT with
8 significant DEGs. The protein expressions of ELN,
ASPN and CHD3 which were encoded by the meaningful
DEGs of CMT, also confirmed the different gene
Figure 4 Validation of the differentially expressed genes by QRT-PCR. Average expression levels of validated 8 genes are shown with their
95% confidence interval. The first to fourth bar means average expression level of T-control and T-CMT from microarray and average level of T-
control and T-CMT from QRT-PCR, respectively. *p < 0.05, **p < 0.01
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Figure 5 Correlation between the QRT-PCR findings and the MRI findings and immumohistochemical staining showing the expression
of the proteins encoded by the DEGs of CMT (X200). The MRI of subjects #1, #2 and #3. Red and green circles indicate the cross sectional
areas of the SCM with or without CMT, respectively. The red arrows indicate the lowest signal areas of CMT. (A). The correlation between the
differences of MRI color intensities and the differences of expressions of 8 DEGs in the tissue with and without CMT for a total of 11
independent patients (B). Immunohistochemical staining shows significantly increased immuno-expression of ELN, ASPN and CHD3 (C).
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expression between the CMT and normal SCM. To the
best of our knowledge, this is the first report that has
examined the transcriptome of human CMT tissue, co-
analyzing the data of the tissue with and without CMT
from the same subjects.
One of the most interesting findings of this study was
that the mRNA expression levels of the CSGs correlated
well with the radiological severity of CMT in terms with
the pre-operational MRI findings of CMT. For example,
THBS4 showed the highest correlation with the neck
MRI findings as seen in Figure 5B. Thrombospondins
(THBSs) are extracellular modular glycoproteins that
function as regulators of collagen fibrillogenesis [23,24].
While THBS4 was one of the top-10 over-expressed
genes in CMT in this study (Table 1), thrombospondin 5
(also known as cartilage oligomeric matrix protein;
COMP) was also over expressed DEGs in CMT among 5
mammalian THBS1~THBS5. While the biological func-
tion of THSB3 and THSB4 has not been clearly known,
THBS4 expression is highly induced at the neuromuscu-
lar junction following injury [25]. It is also expressed in
tendon where it can form mixed pentamers with THBS5
[25-27]. Furthermore, expressions of the three genes
including CHD3, ELN, and asporin, show same correla-
tion between T-CMT and T-control as expressions of
proteins encoded by them. Among the CSGs, however,
the mRNA expressions of three genes including THBS4,
EDIL3 and TNC, were not coincident with those of pro-
tein. It might be caused by post-transcriptional and/or
post-translational regulations. For example, a microRNA
(miRNA) as a post-transcriptional regulator degrades or
silences target mRNAs by binding to complementary
sequences on them [28]. Further studies are needed to
discover which biological processes are associated with
unmatched expression between genes and proteins in
CMT and how they affect the pathogenesis of CMT.
The five CMT-related network modules indicate that
one of the critical pathways to the pathogenesis of CMT is
fibrosis related with collagen and elastin fibrillogenesis
with the evidence of DNA repair mechanism and cytoske-
letal rearrangement possibly related with mechanical
strain. The gene for CHD3 was the most over-expressed
in our study among the subunits of the Mi-2/NuRD com-
plex (Figure 3A). The complex Mi-2/NuRD is the only
known protein entity that uniquely possesses both nucleo-
some remodeling and histone deacetylase activities and it
is a novel regulator of DNA damage responses [22,29]. We
also found fibrosis-related pathways in CMT. ELN was dif-
ferentially over-expressed in CMT along with other genes
that are related with elastic fiber formation such as FBN
[30]. Figure 3E shows a module representing cytoskeletal
rearrangement related with mechanical strain, especially
regarding microtubule dynamic instability. Microtubule is
a polymeric tubulin which is responsible for cellular
integrity as one of cytoskeletons. When cells experience
cellular strain, microtubule tends to depolymerize, ending
up with the form of dimer.
This study has several limitations to be considered. First,
the differentiation of tissue with CMT and the tissue with-
out CMT from the myectomized tissue was done by the
gross appearance of the tissue. From the tissue that was
myectomized, the tissue that showed a tendon-like appear-
ance of white- or pale-pinkish color was considered tissue
with CMT and the tissue that was at the periphery of
CMT tissue and it looked like normal pinkish muscle was
considered tissue without CMT. Four subjects, who did
not show T-control within the myectomized tissue, were
not able to be enrolled in this study. The heat map of the
hierarchical clustering method also showed that 7 samples
of T-CMT (#1-7) and 2 samples of T-control (#3, #4)
showed similar expression levels compared to the remain-
ing 5 samples of T-control (Figure 2B). The histopatholo-
gic findings of the subject #3 and #4 in the microarray
study showed severe fibrosis, which might explain rela-
tively little amount of T-control. Therefore, contamination
of T-CMT into the T-control could be a possible explana-
tion for this phenomenon. Second, most of the subjects
had physical therapy, including ultrasound. However,
there were 3 subjects (subject#5 in the microarray study,
subjects #1 and #4 in the QRT-PCR study) who did not
receive any physical therapy at all and the gene expression
signature of these subjects showed similar pattern with the
other subjects. Therefore, it is unlikely that the gene
expression profiling could be modified by this interven-
tion. Third, the gene expression signature of CMT shown
in this study is a cross-sectional finding of the intermedi-
ate or advanced stage of CMT. Therefore, we do not know
the acute response to CMT.
Conclusions
In conclusion, we were able to provide an integrative
analysis of CMT from gene expression to clinical indica-
tion. The CMT-related network modules gave us more
in-depth understanding of pathophysiology of CMT.
Based on the results of this study, CMT might be defined
as a developmental disorder of the SCM characterized by
fibrosis, ending up with the shortening of the SCM.
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